Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation

Clinical Rheumatology

Volumn 26, Issue 6, 2007, Pages 991-993

  Giner, Vicgal ^a,b   Oltra, M R ^a   Esteban, M J ^a   Garcia Fuster M J ^a   Salvador, A ^a   Nunez J ^a   Redon J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Hospital Verge dels Lliris   (Spain)

Author keywords

Acute myocardial infarction; Catastrophic antiphospholipid syndrome; Ischemic stroke; Ovarian hyperstimulation syndrome; Valsalva's sinus aneurysm

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; INDOMETACIN; OPIATE; PREDNISONE;

ABDOMINAL DISTENSION; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; CLINICAL ASSESSMENT; CRYOPRESERVATION; ECHOCARDIOGRAPHY; ERGOMETRY; FEMALE; HEART INFARCTION; HUMAN; HYPOKINESIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY HYPERSTIMULATION; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME;

EID: 34250777937     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0231-4     Document Type: Article

References (11)

1. Egbase PE (2000) Severe OHSS: How many cases are preventable? Hum Reprod 15(1):8-10
2. Delvigue A, Rozenberg S (2002) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Hum Reprod Updat 8(6):559-577
3. Murdoch AP, Evbuomwan I (1999) Severe complications of ovarian hyperestimulation syndrome are preventable. Hum Reprod 14(11):2922-2924
4. Balasch J, Fabreques F, Arroyo V (1998) Peripheral arterial vasodilation hypothesis: A new insight into the pathogenesis of ovarian hyperestimulation syndrome. Hum Reprod 13:2718-2730
5. Vinatier D, Dufour P, Cosson M, Houpeau JL (2001) Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 96(1):37-50
6. Balasch J, Creus M, Fabregues F, Reverter JC, Carmona F, Tassies B, Font J, Vanrell JA (1996) Antiphospholipid antibodies and human reproductive failure. Hum Reprod 11(10):2310-2315
7. Luzzana C, Gerosa M, Riboldi P, Meroni PL (2002) Update on the anti-phospholipid syndrome. J Nephrol 15:342-348
8. Meyer O (2003) Hormonal life in systemic lupus and other connective tissue diseases. Gynecol Obstet Fertil 31(9):746-756
9. Guballa N, Sammaritano L, Schwartzman S, Buyon J, Lockshin MD (2000) Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 43(3):550-556
10. Huong du LT, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoa Lefebvre G, Piette JC (2002) Importance of planning ovulation induction therapy in systemic erythematosus and antiphospholipid syndrome: A single center retrospective study of 21 cases and 114 cycles. Semin Arthritis Rheum 32(3):174-188
11. Koo EJ, Rha JH, Lee BI, Kim MO, Ha CK (2002) A case of cerebral infarct in combined Antiphospholipid Antibody and Ovarian Hyperstimulation Syndrome. J Korean Med Sci 17:574-576